Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.

@article{Krishnan2005DurableRW,
  title={Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.},
  author={Amrita Y. Krishnan and Arturo Molina and John A Zaia and David K Smith and Debbie Vasquez and Neil M Kogut and Peter M. Falk and Joseph Rosenthal and Joseph C. Alvarnas and Stephen J. Forman},
  journal={Blood},
  year={2005},
  volume={105 2},
  pages={874-8}
}
The treatment of HIV-associated lymphoma has changed since the widespread use of highly active antiretroviral therapy. HIV-infected individuals can tolerate more intensive chemotherapy, as they have better hematologic reserves and fewer infections. This has led to higher response rates in patients with HIV-associated Hodgkin disease (HD) or non-Hodgkin lymphoma (NHL) treated with chemotherapy in conjunction with antiretroviral therapy. However, for patients with refractory or relapsed disease… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

Stem cell transplantation in strategies for curing HIV/AIDS

AIDS research and therapy • 2016
View 1 Excerpt

Similar Papers

Loading similar papers…